177 related articles for article (PubMed ID: 37345344)
21. Multiple Biomarker Testing Tissue Consumption and Completion Rates With Single-gene Tests and Investigational Use of Oncomine Dx Target Test for Advanced Non-Small-cell Lung Cancer: A Single-center Analysis.
Yu TM; Morrison C; Gold EJ; Tradonsky A; Layton AJ
Clin Lung Cancer; 2019 Jan; 20(1):20-29.e8. PubMed ID: 30243889
[TBL] [Abstract][Full Text] [Related]
22. Impact of the quality of resected thyroid cancer tissue sample on next-generation sequencing testing.
Hatanaka KC; Nakamura K; Katoh R; Ito K; Hirokawa M; Miyauchi A; Matsuno Y; Kano S; Okada Y; Mori J; Ito YM; Hatanaka Y
Pathol Int; 2024 Feb; 74(2):77-86. PubMed ID: 38226479
[TBL] [Abstract][Full Text] [Related]
23. FoundationOne CDx detected an uncovered variant of
Takahashi H; Ogino H; Bando H; Mitsuhashi A; Tsukazaki Y; Yabuki Y; Ozaki R; Yoneda H; Sato S; Hanibuchi M; Nishioka Y
Respir Med Case Rep; 2023; 45():101893. PubMed ID: 37485237
[TBL] [Abstract][Full Text] [Related]
24. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
[TBL] [Abstract][Full Text] [Related]
25. Detection of multiple types of cancer driver mutations using targeted RNA sequencing in non-small cell lung cancer.
Ju S; Cui Z; Hong Y; Wang X; Mu W; Xie Z; Zeng X; Su L; Lin X; Zhang Z; Zhang Q; Song X; You S; Chen R; Chen W; Xu C; Zhao J
Cancer; 2023 Aug; 129(15):2422-2430. PubMed ID: 37096747
[TBL] [Abstract][Full Text] [Related]
26. Developing an effective quality evaluation strategy of next-generation sequencing for accurate detecting non-small cell lung cancer samples with variable characteristics: a real-world clinical practice.
Rao W; Guo L; Ling Y; Dong L; Li W; Ying J; Li W
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4889-4897. PubMed ID: 36305947
[TBL] [Abstract][Full Text] [Related]
27. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
[TBL] [Abstract][Full Text] [Related]
28. Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase.
Ceppi P; Volante M; Saviozzi S; Rapa I; Novello S; Cambieri A; Lo Iacono M; Cappia S; Papotti M; Scagliotti GV
Cancer; 2006 Oct; 107(7):1589-96. PubMed ID: 16955506
[TBL] [Abstract][Full Text] [Related]
29. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
Velizheva NP; Rechsteiner MP; Wong CE; Zhong Q; Rössle M; Bode B; Moch H; Soltermann A; Wild PJ; Tischler V
Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
[TBL] [Abstract][Full Text] [Related]
30. Suitability of Bronchoscopic Biopsy Tissue Samples for Next-Generation Sequencing.
Murakami S; Yokose T; Nemoto D; Suzuki M; Usui R; Nakahara Y; Kondo T; Kato T; Saito H
Diagnostics (Basel); 2021 Feb; 11(3):. PubMed ID: 33668993
[TBL] [Abstract][Full Text] [Related]
31. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency.
Bustamante Alvarez JG; Janse S; Owen DH; Kiourtsis S; Bertino EM; He K; Carbone DP; Otterson GA
Clin Lung Cancer; 2021 Jul; 22(4):e519-e527. PubMed ID: 33414052
[TBL] [Abstract][Full Text] [Related]
33. Enhancing tumour content and tumour cell count using microdissection contributes to higher detection rate of genetic mutations by next-generation sequencers.
Tamiya A; Kanaoka K; Inagaki Y; Taniguchi Y; Nakao K; Matsuda Y; Okishio K; Takeda M; Kasai T; Shigeki S
Heliyon; 2023 Nov; 9(11):e22082. PubMed ID: 38027827
[TBL] [Abstract][Full Text] [Related]
34. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
[TBL] [Abstract][Full Text] [Related]
35. Genomic characteristics of driver genes in Chinese patients with non-small cell lung cancer.
Si X; Pan R; Ma S; Li L; Liang L; Zhang P; Chu Y; Wang H; Wang M; Zhang X; Zhang L
Thorac Cancer; 2021 Feb; 12(3):357-363. PubMed ID: 33300283
[TBL] [Abstract][Full Text] [Related]
36. Targeted RNA sequencing with touch imprint cytology samples for non-small cell lung cancer patients.
Seto K; Masago K; Fujita S; Haneda M; Horio Y; Hida T; Kuroda H; Hosoda W; Okubo KI
Thorac Cancer; 2020 Jul; 11(7):1827-1834. PubMed ID: 32372482
[TBL] [Abstract][Full Text] [Related]
37. Validation of the Oncomine
Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
[TBL] [Abstract][Full Text] [Related]
38. Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.
Bonanno L; Pavan A; Ferro A; Calvetti L; Frega S; Pasello G; Aprile G; Guarneri V; Conte P;
Oncologist; 2020 Dec; 25(12):e1996-e2005. PubMed ID: 32557976
[TBL] [Abstract][Full Text] [Related]
39. Clinical next-generation sequencing in patients with non-small cell lung cancer.
Hagemann IS; Devarakonda S; Lockwood CM; Spencer DH; Guebert K; Bredemeyer AJ; Al-Kateb H; Nguyen TT; Duncavage EJ; Cottrell CE; Kulkarni S; Nagarajan R; Seibert K; Baggstrom M; Waqar SN; Pfeifer JD; Morgensztern D; Govindan R
Cancer; 2015 Feb; 121(4):631-9. PubMed ID: 25345567
[TBL] [Abstract][Full Text] [Related]
40. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
Zheng R; Shen Q; Mardekian S; Solomides C; Wang ZX; Evans NR
J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e71-e79. PubMed ID: 32007245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
